Dechert LLP advised Biomunex Pharmaceuticals, a biopharmaceutical company focused on providing immuno-therapeutics through the discovery and development of bi- and multi-specific antibodies, in its announced licensing agreement with Sanofi.
Under the terms of the agreement, Sanofi will have access to Biomunex’ proprietary technology to generate and optimize bi- and multi-specific antibody therapeutics.
Gide, working alongside Australian law firm Allens, has advised Naval Group, the European leader in naval defence and its subsidiary Naval Group Australia Pty Ltd, on the Strategic Partnering Agreement with the Commonwealth Government for Australia's AUD 50 billion (EUR 31 billion) Attack Class Submarine Program.
This Program is the largest Commonwealth defence procurement in Australia and is among the largest defence procurements in the world.
Gowling WLG's life sciences team has acted for clinical-stage biotechnology company argenx in its global collaboration and license agreement with Halozyme Therapeutics, Inc. Argenx is a biotechnology company headquartered in Belgium and focused on the clinical development of novel antibody-based therapies.
As part of the transaction, argenx gains access to Halozyme's ENHANZE® drug delivery technology to develop subcutaneous product formulations for current or future argenx product candidates.
Shearman & Sterling advised Investcorp on the launch of a joint venture with Aberdeen Standard Investments that will invest in infrastructure projects in Gulf Cooperation Council countries. They plan to raise between $800 million and $1 billion. The new initiative will actively target greenfield and brownfield social and core essential infrastructure assets in sectors including healthcare, education, utilities, social housing, smart cities, roads and rail.
International law firm CMS has advised investment company, the Noe Group, and its technology arm, Goldacre on its 50:50 partnership with Legal & General Capital to expand its £230 million Kao data centre campus that will serve life science and technology businesses along the London to Cambridge innovation corridor.
Sidley Represents Dermira, Inc. in an Option and License Agreement With Almirall, S.A. for European Rights to Lebrikizumab
LONDON, February 12, 2019 – Morgan Lewis is advising Heritage Capital on its acquisition of a controlling interest in luxury travel company Abercrombie & Kent, Group of Companies S.A., and a strategic partnership with Geoffrey J.W. Kent, its founder, chairman, and CEO. Following the acquisition, Heritage Capital will own 85% of Abercrombie & Kent and Mr. Kent will own 15%.
The international law firm BEITEN BURKHARDT has extensively assisted the German Football Association Deutscher Fußball-Bund (DFB) with the partnership with the leading German sports betting provider bwin.
Taylor Wessing has advised the Departement du Nord on a significant procurement procedure and partnership agreement worth more than EUR 90 million.
The agreement will allow for the construction of a new building consolidating all of the Department's services onto a single site in the heart of the City of Lille.